Search Results (1,007)

Nanomaterials (NMs) have shown broad application potential in wastewater deep treatment, but the actual application is constrained by some issues such as nanoparticle (NP) aggregation and poor recyclability. Different from previous comprehensive reviews, this article systematically synthesizes data from over 100 peer-reviewed studies (2012 to 2026) to review the preparation methods, purification mechanisms, and removal efficiencies for various pollutants, and the technical and economic feasibility of NMs, with an emphasis on carrier-assisted immobilization and NM–microbial aggregate interactions. To start with, the methods of preparation were roughly distinguished into two categories which were “top-down” and “bottom-up” methods. The advantages, disadvantages, and utilities of the physical, chemical, and eco-friendly methods of biosynthesis were investigated while paying particular attention to the function of the loading technique in preventing NP aggregation and improving recyclability. By using the technique of loading in the carrier, the growth of NPs could be restricted up to 2–50 nm. Secondly, seven basic mechanisms that underlie the process of removing pollutants by using NPs were explained: adsorption, catalytic degradation, ion exchange, surface complexation, antibacterial action, redox transformation, and waste recycling. Particular focus was placed on understanding the interactions between NMs, microbial aggregates, and extracellular polymeric substances in wastewater treatment systems. Extracellular polymeric substances (EPS) could capture >90% NMs and mitigate their toxicity. Once again, the removal efficiency and main influencing factors associated with different types of NMs, for the treatment of heavy metals, dyes, antibiotics, and pathogenic microorganisms were summarized. Removal efficiencies of the pollutants ranged from 70% to over 99%, but these values were strongly influenced by pH and matrix and often decreased substantially in real wastewater. The existing literature was used to classify the experimental substrates (single-solute systems, multi-solute synthetic systems, municipal wastewater, industrial wastewater, secondary effluent). The performance of NMs in different categories was compared, revealing the huge performance gap between ideal laboratory conditions and practical applications. Lastly, the economic viability of the methods based on the use of NMs for purifying water was assessed taking into consideration various factors such as raw materials’ prices, energy costs of the process of making materials, recyclability of the materials, and the possibility of introducing the use of NMs on a larger scale. Unlike existing reviews, this article aims to provide a quantitative mechanistic framework bridging the rational design, safe application, and engineering promotion of NMs in deep wastewater treatment. Full article

Lactococcosis, caused by Lactococcus garvieae, is a persistent problem of farmed rainbow trout, and the reduced efficacy of conventional antibiotics has prompted interest in plant-derived alternatives. The in vitro antibacterial activity of five commercial essential oils from Melaleuca alternifolia, Mentha piperita, Citrus limon, Rosmarinus officinalis and Lavandula hybrida was evaluated against six L. garvieae isolates from rainbow trout. Minimum inhibitory and minimum bactericidal concentrations (MIC and MBC) were determined by broth microdilution, and the mode of action was defined by the MBC/MIC ratio; susceptibility to oxytetracycline (OTC) and trimethoprim–sulfamethoxazole (SXT) was also assessed. The major constituents were terpinen-4-ol (tea tree), menthol (peppermint), limonene (lemon), 1,8-cineole (rosemary) and linalool (lavandin). Activities were strain-dependent, with MIC values mostly from 6.25 to 100% (v/v) (single lowest, 1.5625% for rosemary), and lemon was among the least active, but the Kruskal–Wallis test showed no significant differences among oils (p > 0.05), so these differences are descriptive only. Where effective, the oils acted mainly through a bactericidal mechanism (MBC/MIC ≤ 4), but only at high concentrations, so their practical significance appears limited. All six isolates were resistant to OTC (MIC 8–16 µg/mL) and SXT (MIC 8–32 µg/mL). In vivo studies are required before practical use. Full article

Gastric cancer is one of the malignancies with the highest incidence and mortality worldwide. Helicobacter pylori (H. pylori) infection is the primary driving factor in its development. The progression of gastric mucosal malignancy follows the Correa cascade model: “chronic non-atrophic gastritis → chronic atrophic gastritis (CAG) → intestinal metaplasia (IM) → dysplasia (Dys) → gastric cancer.” Currently, clinical management faces major challenges, including increasing antibiotic resistance in H. pylori, limited pharmacological options for gastric precancerous lesions, and treatment resistance and toxicity in established gastric cancer. This review synthesizes current evidence on BBR, COP, EPI, PAL, and JAT and organizes their reported actions into a three-tier intervention framework. At the first tier, etiologic and inflammatory interception, individual alkaloids suppress H. pylori persistence through direct antibacterial injury, urease inhibition, and modulation of bacterial virulence and antibiotic susceptibility, while attenuating infection-driven inflammatory and immune responses. At the second tier, modulation of precancerous mucosal progression, preclinical studies indicate that these compounds can ameliorate gastric glandular injury and may attenuate biological processes associated with progression toward intestinal metaplasia and dysplasia. At the third tier, antitumor and adjunctive intervention in established gastric cancer, alkaloids inhibit proliferation, induce cell-cycle arrest and apoptosis, suppress invasion and metastasis, and regulate non-coding RNA and epigenetic networks; BBR-centered preclinical studies further suggest potential chemosensitizing and supportive effects. This review integrates the five alkaloids BBR, COP, EPI, PAL, and JAT and systematically elucidates their mechanisms of action across the pathological continuum from H. pylori infection and chronic inflammation to precancerous lesions and ultimately gastric cancer. It establishes a stage-oriented, compound-specific analytical framework to clarify the pharmacological positioning of these compounds, identify priorities requiring further validation, and guide future mechanistic and translational research. Full article

Pseudomonas syringae pv. actinidiae (Psa) is the most destructive pathogen of kiwifruit, and the absence of curative measures makes the management of Psa-induced kiwifruit bacterial canker (KBC) particularly challenging. Elettaria cardamomum produces an essential oil (CAR) rich in bioactive compounds with demonstrated potential to act directly against Psa, but its mechanisms of action remain insufficiently explored. Here, we investigated CAR’s mode of action in plants with established mild KBC symptoms, and assessed its potential as a plant elicitor. In the in planta assay, CAR application (0.1% w/v, applied 7 days after inoculation) reduced KBC symptoms, with the strongest effect observed 14 days after treatment (DAT). However, CAR did not significantly affect oxidative stress biomarkers, antioxidant system, pigments and primary metabolism, or the expression of target genes related to systemic acquired resistance or salicylic acid and jasmonic acid pathways. For instance, Psa inoculation significantly upregulated PR1 (≈5.4-fold) and PR5 (≈4.3–5.5-fold), irrespective of CAR application. Complementary in vitro assays revealed a transient, phase-dependent antimicrobial activity of CAR: although the effect disappeared by 32 h in liquid-phase assay and no inhibition was observed under vapor-phase exposure, a strong reduction in Psa viable cells (79.7%) was observed after 8 h exposure in the liquid phase. This study demonstrates that CAR exerts a direct, albeit transient, antibacterial effect against Psa, conferring curative activity when applied to plants with mild KBC symptoms. Consequently, repeated applications may be required to maintain disease suppression, as CAR does not appear to induce a sustained preventive defense response in the host. Full article

Itaconic acid has been reported to possess anti-inflammatory and antibacterial properties. However, its specific mechanisms of action against pathogenic bacteria, especially in the context of purine metabolism, remain poorly understood. Here, we investigate the impact of itaconic acid on the purine metabolism of PCN033, a highly pathogenic porcine extraintestinal pathogenic Escherichia coli (ExPEC) strain. Our in vitro and in vivo experiments demonstrated that itaconic acid significantly inhibited the proliferation of PCN033. Multi-omics analyses, including transcriptome and metabolome sequencing, revealed that itaconic acid severely disrupted the purine metabolism pathway of PCN033. Further mechanistic studies identified PRPP amidotransferase (PurF), a key enzyme in de novo purine synthesis, as a direct target of itaconic acid. Molecular docking and click chemistry experiments provided compelling evidence that itaconic acid specifically binds to the second cysteine residue (2C) of PurF, leading to the inhibition of its enzymatic activity. These data reveal a novel and critical mechanism by which itaconic acid exerts its antibacterial effects in response to bacterial infection. Importantly, our in vivo data show that supplementation with itaconic acid alleviated weight loss, organ damage, and inflammatory responses induced by PCN033 infection in mice and nursery pigs. These novel findings enhance our understanding of the antibacterial mechanisms of itaconic acid. Supplementation with itaconic acid could serve as a therapeutic strategy for treating pathogenic bacterial infections in humans and other animals. Full article

Staphylococcus aureus (S. aureus) is a prominent foodborne pathogen that poses a continuous threat to global public health and food safety due to its possession of a variety of toxins and its multidrug resistance. Medium-chain fatty acids (MCFAs), notably lauric acid (LA), exhibit strong antimicrobial properties, but their application is heavily constrained by poor water solubility. In this study, optimized LA emulsions stabilized by chitosan (CS) and polyvinyl alcohol (PVA) were evaluated for their antibacterial activity and detailed mode of action against S. aureus ATCC 6538. The antibacterial activities were evaluated by the maximum inhibition zone, with the 20 CS-PVA/DLTA-LA formulation exhibiting stable dispersion and potent antibacterial activity at 1%. The underlying antibacterial mechanisms against S. aureus were specifically focused on cell membranes and peptidoglycan. Therein, the binding of emulsion droplets to the anionic bacterial surface was driven by electrostatic attraction. Membrane degradation was also observed with membrane dysfunctions involving membrane depolarization, increased permeability, and fluidity reduction triggered by their subsequent insertion into the lipid bilayer, which may cause cell dysmetabolism, disintegration, and eventual cell death. Overall, these findings substantiate that LA emulsions disrupt S. aureus by operating potentially multi-targeted effects involving cell membrane disruption and peptidoglycan interference, offering a promising alternative approach warranting further investigation for foodborne pathogen control. Full article

Background: Geranium robertianum L. (GR) is a perennial herbaceous plant that belongs to the Geraniaceae family, widely distributed across temperate regions of Europe, Asia, North Africa, and America. It has been used in traditional ethnomedicine for its antibacterial, haemostatic, and anti-allergic properties in the treatment of oropharyngeal conditions, wounds, and inflammatory diseases. Beyond these traditional applications, pharmacological studies have documented several biological activities of its extracts and constituents. Objective: The aim of this review is to evaluate the therapeutic potential of GR by examining the phytochemical composition and the pharmacological properties relevant to dental medicine. Methods: A literature screening was conducted (PubMed, Google Scholar, PubMed Central), with focus on studies concerning phytochemical composition, pharmacological effects, and potential applications of GR and its major bioactive constituents in oral health. Results: Phytochemical analysis reveals that GR is characterized by a rich content of polyphenols, particularly tannins, flavonoids, and phenolic acids, with geraniin, ellagic acid, gallic acid, quercetin, and kaempferol identified as its principal bioactive constituents. Recent studies have confirmed that these constituents are responsible for the plant’s therapeutic potential in oral medicine. These compounds possess a variety of effects, from antibacterial and anti-inflammatory properties to antifungal and antiviral activities, as well as antioxidant, wound-healing, and anticancer benefits relevant to dental medicine. Conclusions: Despite its long-standing traditional use, GR remains largely underexplored in the context of oral health. This gap in the literature highlights GR as a promising phytotherapeutic candidate, calling for further in vitro and in vivo studies in order to investigate its efficacy and establish its mechanism of action in dental medicine. Full article

Hyptis eriocephala is an aromatic Lamiaceae species from southern Ecuador whose essential oil has not previously been characterized. To establish an initial phytochemical and biological baseline, aerial parts collected at Villonaco were subjected to three independent steam-distillation runs, yielding 0.13 ± 0.04% (w/w) essential oil. Volatile constituents were tentatively assigned by GC–MS using concordant EI mass-spectral and linear retention-index evidence, whereas relative composition was determined by GC–FID peak-area normalization without an internal standard, calibration curves, or response correction factors. Sixty-five constituents accounted for 96.81% of the total GC–FID peak area. The relative profile was dominated by hydrocarbon sesquiterpenes (67.88%), followed by hydrocarbon monoterpenes (24.36%), with α-copaene (28.20 ± 0.24%), germacrene D (9.29 ± 0.09%), α-pinene (6.98 ± 0.03%), α-cubebene (6.70 ± 0.06%), δ-cadinene (6.03 ± 0.07%), limonene (5.44 ± 0.05%), (E)-caryophyllene (5.31 ± 0.05%), and β-phellandrene (4.96 ± 0.02%) were the principal constituents. The oil showed a narrow antibacterial response, with MIC values of 250 µg/mL against Enterococcus faecium ATCC 27270 and 2000 µg/mL against Enterococcus faecalis ATCC 19433. Radical-scavenging activity was assay-dependent: activity was measurable in the ABTS assay (SC₅₀ = 76.87 ± 1.05 µg/mL; TEAC = 30.06 ± 1.16 µM TE/g EO), whereas 50% DPPH scavenging was not reached at 8000 µg/mL. The oil preferentially inhibited BuChE (IC₅₀ = 125.3 ± 1.03 µg/mL) over AChE (IC₅₀ = 385.9 ± 1.02 µg/mL). These findings establish a preliminary phytochemical and biological baseline for the Villonaco material but do not demonstrate a species-wide chemotype, mechanism of action, or therapeutic potential. Full article

Yucca schidigera extract (YSE) is a plant-derived feed additive rich in steroidal saponins, polyphenols, and polysaccharides, with demonstrated anti-inflammatory, antioxidant, antibacterial, and ammonia-binding properties. This review systematically synthesizes the major bioactive components, core mechanisms of action, including modulation of the Nrf2/ARE and NF-κB pathways, regulation of ruminal fermentation and ammonia-nitrogen metabolism, and maintenance of intestinal barrier integrity, and the species-specific application effects of YSE in pigs, poultry, ruminants, and aquatic animals. Most studies have shown that YSE can improve growth performance, reproductive efficiency, and product quality while concurrently reducing ammonia and methane emissions. However, the magnitude and consistency of these benefits vary considerably across species, dosage, and experimental conditions, with most evidence derived from controlled trials rather than commercial-scale validation. By integrating cross-species dose–response data and identifying critical knowledge gaps, including product standardization, long-term safety, and economic feasibility under commercial conditions, this review provides a theoretical and practical foundation for the evidence-based application of YSE as a sustainable feed additive. In the context of global efforts to reduce antibiotic use and mitigate environmental pollution from livestock production, YSE represents a promising, multifunctional tool for advancing ecological and low-carbon animal husbandry. Full article

The escalating crisis of bacterial antimicrobial resistance necessitates the discovery of novel antibacterial agents with distinct mechanisms of action. Ursolic acid (UA), a naturally abundant pentacyclic triterpenoid, serves as a promising scaffold for structural modification. In this study, a series of 26 novel UA derivatives (A1–A7 and B1–B19) were designed and synthesized by introducing various substituents at the C-28 carboxyl group via a chloroacetyl chloride linker. Their antibacterial activities were evaluated against S. aureus, S. epidermidis, E. coli, and P. aeruginosa using the microbroth dilution method. Among them, compound B1 exhibited the most potent activity, with a minimum inhibitory concentration (MIC) of 37.5 μg/mL against S. aureus and 75 μg/mL against E. coli. Antibacterial kinetic and time-kill curve assays confirmed the sustained bactericidal effect of B1. Furthermore, B1 significantly inhibited biofilm formation in both S. aureus and E. coli in a time-dependent manner. Molecular docking studies revealed that B1 binds spontaneously to the S. aureus SarA protein through three hydrogen bonds and π-π stacking interactions, providing a structural basis for its antibacterial and anti-biofilm activities. This study demonstrates that piperazine-modified UA derivative B1 is a promising antibacterial candidate and offers a new strategy for the structural optimization of ursolic acid. Full article

Melanoma excision procedures frequently result in complex wounds that require simultaneous tumor suppression and tissue regeneration. However, current post-surgical care heavily relies on synthetic drugs, facing challenges like antibiotic resistance and delayed healing. To address this notable gap, this study introduces a novel “mineral-botanical” hybrid nanofibrous dressing to reduce reliance on conventional synthetic agents. The nanofiber surfaces were subsequently functionalized with a supercritical CO₂ extract of Inula helenium, thereby introducing a highly bioactive botanical agent not previously explored in this hybrid wound-care context. Comprehensive physical and structural characterizations demonstrated that the bioactive coating serves as a resilient physical barrier, significantly enhancing the dressing’s structural integrity in fluidic environments. In vitro biological evaluations revealed a dual-action mechanism: the biomaterial exhibited excellent biocompatibility and accelerated migration in human dermal fibroblasts (HDFs), achieving nearly 100% in vitro wound closure at 24 h. Conversely, the Inula helenium-coated nanofibers demonstrated distinct, selective cytotoxicity against A375 melanoma cells, effectively restricting their proliferation and reducing their viability. Furthermore, the hybrid platform exhibited significant antioxidant potential and achieved 94% antibacterial inhibition against Staphylococcus aureus. In conclusion, this study presents a sustainable, dual-function wound dressing that suppresses residual cancer cells while promoting healthy tissue regeneration, offering a promising alternative to conventional synthetic oncological dressings. Full article

The chronic overuse of antibiotics has accelerated the emergence of antibiotic-resistant bacteria, creating a global public health crisis as conventional therapies fail against multidrug-resistant pathogens spreading through water and food chains. Cadmium sulfide (CdS) has been established as an important visible-light-driven photocatalyst for antibacterial applications. This brief review systematically examines the structure–property relationships governing CdS-based antibacterial materials, including crystallographic polymorphs (cubic sphalerite and hexagonal wurtzite), morphological diversity from quantum dots to hierarchical architectures, and synthesis methodologies that critically influence particle size, crystallinity, and surface chemistry. The mechanisms of antibacterial action are elucidated, encompassing photocatalytic reactive oxygen species (ROS) generation, controlled Cd²⁺ ion release, and membrane disruption. A detailed tabulated analysis is presented across three material classes: pristine CdS, binary composites, and ternary Z-scheme heterostructures. Density functional theory (DFT) calculations and molecular docking simulations provide atomic-level insights into charge transfer dynamics and enzyme inhibition mechanisms. Finally, critical challenges, photocorrosion, toxicity, biocompatibility concerns, and scalability limitations are addressed. This review bridges fundamental materials science with antimicrobial applications to guide rational design of next-generation CdS-based antibacterial materials. Full article

The increasing prevalence of antimicrobial resistance has stimulated the development of alternative antimicrobial materials capable of preventing microbial growth and biofilm formation. Chitosan, a natural polysaccharide derived from chitin through deacetylation, possesses intrinsic antimicrobial properties, biodegradability, biocompatibility, and low toxicity, making it an attractive matrix for nanocomposite materials. However, the antimicrobial efficacy of pure chitosan is often limited by different factors, such as pH sensitivity, mechanical weakness, and poor solubility at neutral pH. To overcome these limitations, researchers have developed chitosan composites containing nanoparticles to enhance antimicrobial and antibacterial efficacy. This review provides an update on the status of the action mechanisms, synthesis methods, antimicrobial and antibacterial performances, and potential biomedical applications of chitosan-based composites containing silver nanoparticles (AgNPs) or zinc oxide nanoparticles (ZnONPs). Full article

Background/Objectives: Dittrichia viscosa (L.) W. Greuter (Asteraceae) is a Mediterranean medicinal plant whose polar phenolic fraction remains insufficiently characterized. This study aimed to characterize the phenolic composition and evaluate the antioxidant, antimicrobial, and mechanistic bioactivity of aqueous and methanolic leaf extracts collected from the Rmilate Forest in Tangier, northern Morocco. Methods: Extracts were characterized by ICP-AES for elemental content and by HPLC-PDA-ESI-MS for phenolic annotation, and total phenolic, flavonoid, and tannin contents were quantified. Antioxidant capacity was assessed using DPPH, ABTS, FRAP, and ORAC assays. Antibacterial activity was evaluated against four reference strains, with time–kill kinetics and membrane integrity assays used to probe the mechanism of action, and antifungal activity was tested against dermatophytic and phytopathogenic fungi. Molecular docking against four bacterial, fungal, and antioxidant enzyme targets and ProTox-3 toxicity prediction were also performed. Results: ICP-AES revealed high concentrations of calcium (12,476.75 mg/kg) and potassium (29,699 mg/kg). The methanolic extract showed higher total phenolic (55.05 mg GAE/g), flavonoid (84.18 mg QE/g), and tannin (262.1 mg TAE/g) contents and superior antioxidant activity (DPPH IC₅₀: 0.090 mg/mL). Twelve phenolic compounds were tentatively annotated, including caffeic acid, caffeoylquinic acid derivatives, and quercetin/kaempferol glycosides. Antibacterial activity (MIC: 0.25–1 mg/mL) was consistent with cell envelope disruption, and up to 88% mycelial inhibition was achieved against Trichophyton rubrum. Docking ranked kaempferol-3-O-pentoside (−10.3 kcal/mol) among the top-scoring ligands, and the top compounds were assigned to toxicity class 5. Conclusions:D. viscosa is a promising source of bioactive phenolics for pharmaceutical and agrochemical development. Full article

The purpose of this review is to highlight the complex influence of antibiotics on human fertility and the need for them not to be underestimated. In creating this review article, data and information from the following international databases were used: PubMed, Scopus and Clarivate Analytics. Only full text articles were used. Antibacterial antibiotics are a group of drugs essential in fighting infections, having multiple mechanisms of action at the level of the bacterial cell; but at the same time they also act on human cells. One of the important actions of antibiotics is on fertility. There are both experimental and clinical data showing the influence of some antibiotics on fertility. There are both positive and negative influences of these drugs on fertility. Some of the most important actions with a positive impact on fertility are: therapy of pelvic infections in women, treatment of endometritis, reduction in post-abortion infections, treatment of infections of the male genital tract—infections that reduce fertility. The most important negative implications of some antibiotics are the direct effects of reducing the production of gametes, decreasing the activity or quality of the gametes, reducing the synthesis of sexual hormones and negative influences on the evolution of pregnancy, including spontaneous abortion in some cases. Other negative influences are produced by the direct action of some antibiotics on the embryo. Some antibiotics such as azithromycin and nitrofurantoin increase the risk of miscarriage. Although only a limited number of antibiotics are known to have an influence on fertility, this influence should not be underestimated in clinical practice. Full article